Upgrades:
Wells Fargo & Company (NYSE:WFC) was upgraded by equities researchers at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research note issued on Monday, The Fly reports.
A number of other research analysts have also recently
issued reports on the company. BMO Capital Markets reduced their price
objective on Wells Fargo & Company from $35.00 to $31.00 and set a “market
perform” rating on the stock in a research note on Friday, October 16th. DA
Davidson raised Wells Fargo & Company from a “neutral” rating to a “buy”
rating and lifted their price target for the stock from $27.00 to $31.00 in a
research note on Thursday, November 19th. ValuEngine raised Wells Fargo &
Company from a “hold” rating to a “buy” rating in a research note on Wednesday,
November 25th. Odeon Capital Group upgraded shares of Wells Fargo & Company
from a “hold” rating to a “buy” rating in a report on Wednesday, September 2nd.
Finally, UBS Group upgraded shares of Wells Fargo & Company from a “sell”
rating to a “neutral” rating and upped their price target for the company from
$21.00 to $24.00 in a report on Friday, September 11th. One equities research
analyst has rated the stock with a sell rating, fourteen have issued a hold
rating and eleven have given a buy rating to the stock. The stock currently has
a consensus rating of “Hold” and a consensus target price of $31.30. Read
more …
AstraZeneca (NYSE:AZN) was upgraded by equities researchers at UBS Group from a "sell" rating to a "neutral" rating in a note issued to investors on Monday, The Fly reports.
Other equities research analysts also recently issued
research reports about the company. HSBC raised AstraZeneca from a
"reduce" rating to a "hold" rating in a research report on
Wednesday, November 11th. Berenberg Bank initiated coverage on AstraZeneca in a
research report on Tuesday, September 29th. They set a "buy" rating
on the stock. Oddo Bhf raised AstraZeneca from a "reduce" rating to a
"buy" rating in a research report on Wednesday, September 23rd.
Finally, Morgan Stanley reaffirmed an "equal weight" rating on shares
of AstraZeneca in a research report on Monday, November 23rd. One research
analyst has rated the stock with a sell rating, five have issued a hold rating
and seven have assigned a buy rating to the company's stock. The company currently
has a consensus rating of "Hold" and a consensus target price of
$61.00.
AZN opened at $52.61 on Monday. AstraZeneca has a 12-month
low of $36.15 and a 12-month high of $64.94. The company has a current ratio of
0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 1.14. The business's
fifty day simple moving average is $53.81 and its 200-day simple moving average
is $54.53. The company has a market capitalization of $138.08 billion, a
price-to-earnings ratio of 63.39, a PEG ratio of 1.63 and a beta of 0.50. Read
more …
The Bank of New York Mellon (NYSE:BK) was upgraded by investment analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating in a note issued to investors on Monday, The Fly reports.
Several other equities analysts have also recently commented
on the stock. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon
Russell cut shares of The Bank of New York Mellon from a "buy" rating
to a "neutral" rating in a report on Tuesday, November 10th. Deutsche
Bank Aktiengesellschaft upgraded shares of The Bank of New York Mellon from a
"hold" rating to a "buy" rating and boosted their price
target for the company from $39.00 to $46.00 in a report on Wednesday, November
11th. Smith Barney Citigroup cut shares of The Bank of New York Mellon from a
"buy" rating to a "neutral" rating in a report on Tuesday,
November 10th. Bank of America cut shares of The Bank of New York Mellon from a
"neutral" rating to an "underperform" rating and lowered
their price target for the company from $42.00 to $39.00 in a report on Friday,
November 20th. Finally, Keefe, Bruyette & Woods cut shares of The Bank of
New York Mellon from an "outperform" rating to a "market
perform" rating and lowered their price target for the company from $47.00
to $43.00 in a report on Wednesday, November 18th. Three equities research
analysts have rated the stock with a sell rating, ten have assigned a hold
rating and nine have assigned a buy rating to the company's stock. The Bank of
New York Mellon has a consensus rating of "Hold" and an average
target price of $44.56. Read
more …
U.S. Bancorp (NYSE:USB) was upgraded by investment analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating in a research note issued on Monday, The Fly reports.
USB has been the subject of a number of other research
reports. Bank of America raised shares of U.S. Bancorp from an “underperform”
rating to a “neutral” rating and lifted their price objective for the company
from $39.00 to $41.00 in a research report on Wednesday, October 7th. JPMorgan
Chase & Co. raised their price target on shares of U.S. Bancorp from $37.50
to $43.50 and gave the stock an “underweight” rating in a research report on
Tuesday, October 6th. ValuEngine raised shares of U.S. Bancorp from a “sell”
rating to a “hold” rating in a report on Monday, November 2nd. Finally,
TheStreet raised shares of U.S. Bancorp from a “c” rating to a “b-” rating in a
report on Thursday, October 15th. Two research analysts have rated the stock
with a sell rating, ten have given a hold rating and eleven have given a buy
rating to the company. U.S. Bancorp presently has a consensus rating of “Hold”
and a consensus target price of $44.58. Read
more …
Enbridge (NYSE:ENB) (TSE:ENB) was upgraded by research analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating in a research report issued on Monday, The Fly reports.
A number of other analysts also recently weighed in on ENB.
TD Securities decreased their price target on shares of Enbridge from $57.00 to
$53.00 and set a “buy” rating for the company in a research report on Monday,
November 9th. Royal Bank of Canada decreased their price target on shares of
Enbridge from $58.00 to $52.00 and set an “outperform” rating for the company
in a research report on Monday, November 9th. Stifel Nicolaus decreased their
price target on shares of Enbridge from $61.00 to $59.00 and set a “buy” rating
for the company in a research report on Monday, November 9th. ValuEngine
downgraded shares of Enbridge from a “hold” rating to a “sell” rating in a
research report on Monday, August 3rd. Finally, Citigroup raised shares of
Enbridge from a “neutral” rating to a “buy” rating and set a $50.00 price
target for the company in a research report on Thursday, August 13th. Two
research analysts have rated the stock with a sell rating, one has given a hold
rating and seventeen have assigned a buy rating to the company. Enbridge has a
consensus rating of “Buy” and a consensus price target of $51.33. Read
more …
Welltower (NYSE:WELL) was upgraded by stock analysts at Bank of America from an "underperform" rating to a "neutral" rating in a research report issued on Monday, The Fly reports.
Several other research firms have also recently commented on
WELL. Mizuho cut Welltower from a "buy" rating to a
"neutral" rating and boosted their target price for the stock from
$51.00 to $57.00 in a research note on Friday, October 16th. BMO Capital
Markets reaffirmed a "hold" rating and set a $52.00 price target on
shares of Welltower in a report on Wednesday, August 5th. Wells Fargo &
Company downgraded Welltower from an "overweight" rating to an
"equal weight" rating and lifted their price target for the stock
from $54.00 to $63.50 in a report on Monday, November 16th. Evercore ISI downgraded
Welltower from an "outperform" rating to an "in-line"
rating and set a $64.00 price target for the company. in a report on Friday,
November 13th. Finally, Jefferies Financial Group raised Welltower from an
"underperform" rating to a "hold" rating and set a $60.00
price target for the company in a report on Tuesday, November 10th. Seventeen
research analysts have rated the stock with a hold rating and four have given a
buy rating to the company. The stock has a consensus rating of "Hold"
and an average price target of $55.47. Read
more …
Ventas (NYSE:VTR) was upgraded by research analysts at Bank of America from an “underperform” rating to a “buy” rating in a report issued on Monday, The Fly reports.
Other equities research analysts also recently issued
research reports about the stock. Raymond James reiterated a “buy” rating on
shares of Ventas in a research note on Friday, November 6th. ValuEngine
upgraded shares of Ventas from a “sell” rating to a “hold” rating in a research
note on Wednesday, November 11th. Barclays increased their target price on
shares of Ventas from $37.00 to $42.00 and gave the stock an “equal weight”
rating in a research note on Wednesday, September 16th. Argus downgraded shares
of Ventas from a “buy” rating to a “hold” rating in a research note on Tuesday,
September 8th. Finally, Jefferies Financial Group upgraded shares of Ventas
from an “underperform” rating to a “hold” rating and set a $50.00 target price
for the company in a research note on Tuesday, November 10th. Three research
analysts have rated the stock with a sell rating, twelve have assigned a hold
rating and three have assigned a buy rating to the stock. Ventas has a
consensus rating of “Hold” and a consensus price target of $40.63. Read
more …
Omega Healthcare Investors (NYSE:OHI) was upgraded by analysts at Bank of America from an "underperform" rating to a "buy" rating in a report released on Monday, The Fly reports.
OHI has been the subject of a number of other reports.
Mizuho upped their price objective on shares of Omega Healthcare Investors from
$30.00 to $34.00 and gave the stock a "buy" rating in a research note
on Friday, October 2nd. Stifel Nicolaus began coverage on shares of Omega
Healthcare Investors in a report on Tuesday, September 1st. They issued a
"buy" rating and a $35.00 target price for the company. Raymond James
downgraded shares of Omega Healthcare Investors from a "strong-buy"
rating to an "outperform" rating and set a $34.00 target price for
the company. in a report on Monday, August 3rd. Truist boosted their target
price on shares of Omega Healthcare Investors from $32.00 to $34.00 in a report
on Monday, September 14th. Finally, Zacks Investment Research upgraded shares
of Omega Healthcare Investors from a "hold" rating to a
"buy" rating and set a $35.00 price objective on the stock in a
report on Wednesday, October 14th. Two research analysts have rated the stock
with a sell rating, five have given a hold rating and seven have assigned a buy
rating to the company's stock. Omega Healthcare Investors presently has a
consensus rating of "Hold" and an average target price of $32.21. Read
more …
Apple (NASDAQ:AAPL) was upgraded by stock analysts at Loop Capital from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, The Fly reports.
Several other research analysts have also recently issued
reports on AAPL. DZ Bank reissued a “buy” rating on shares of Apple in a
research note on Monday, August 31st. Raymond James lifted their price target
on shares of Apple from $120.00 to $140.00 and gave the company an “outperform”
rating in a research report on Friday, October 30th. DA Davidson lifted their
price target on shares of Apple from $120.00 to $133.00 and gave the company a
“buy” rating in a research report on Friday, October 30th. BNP Paribas raised
shares of Apple from an “underperform” rating to an “outperform” rating and
lifted their price target for the company from $77.00 to $140.00 in a research
report on Friday, September 25th. Finally, BidaskClub raised shares of Apple
from a “buy” rating to a “strong-buy” rating in a research report on Wednesday,
August 5th. Three investment analysts have rated the stock with a sell rating,
sixteen have given a hold rating, twenty-eight have assigned a buy rating and
one has issued a strong buy rating to the company. Apple currently has an
average rating of “Buy” and an average price target of $111.70. Read
more …
Downgrades:
Rockwell Automation (NYSE:ROK) was downgraded by analysts at Barclays from an "overweight" rating to an "equal weight" rating in a research note issued to investors on Monday, The Fly reports. The analysts noted that the move was a valuation call.
ROK has been the subject of several other research reports.
JPMorgan Chase & Co. lifted their price target on Rockwell Automation from
$155.00 to $188.00 and gave the company an "underweight" rating in a
report on Wednesday, October 7th. Morgan Stanley raised Rockwell Automation
from an "equal weight" rating to an "overweight" rating and
lifted their price objective for the company from $267.00 to $288.00 in a
research note on Monday, November 23rd. Zacks Investment Research raised
Rockwell Automation from a "hold" rating to a "buy" rating
and set a $256.00 price objective on the stock in a research note on Friday,
November 13th. Daiwa Capital Markets raised Rockwell Automation from a
"neutral" rating to an "outperform" rating and set a
$240.00 price objective on the stock in a research note on Wednesday, September
23rd. Finally, Wells Fargo & Company reaffirmed a "hold" rating
on shares of Rockwell Automation in a research note on Thursday, November 12th.
Four equities research analysts have rated the stock with a sell rating, nine
have issued a hold rating and eight have given a buy rating to the company. The
stock currently has an average rating of "Hold" and a consensus price
target of $226.47. Read
more …
Bank of America (NYSE:BAC) was downgraded by stock analysts at Morgan Stanley to an "underweight" rating in a research note issued on Monday, Stock Target Advisor reports.
Several other equities analysts also recently commented on
BAC. TheStreet upgraded Bank of America from a "c+" rating to a
"b-" rating in a research report on Tuesday, August 25th. Deutsche
Bank Aktiengesellschaft upgraded Bank of America from a "hold" rating
to a "buy" rating and boosted their target price for the stock from
$27.00 to $29.00 in a research report on Thursday, September 3rd. Royal Bank of
Canada set a $28.00 price objective on Bank of America and gave the stock a
"buy" rating in a research note on Wednesday, October 14th.
Oppenheimer reissued a "buy" rating on shares of Bank of America in a
research note on Tuesday, September 8th. Finally, Credit Suisse Group reissued
a "buy" rating and set a $31.00 price objective on shares of Bank of
America in a research note on Monday, August 3rd. Two equities research
analysts have rated the stock with a sell rating, nine have assigned a hold
rating and twelve have assigned a buy rating to the stock. The stock presently
has an average rating of "Hold" and an average target price of
$29.31. Read
more …
JPMorgan Chase & Co. (NYSE:JPM) was downgraded by equities researchers at Morgan Stanley from an “overweight” rating to an “underweight” rating in a research report issued on Monday, The Fly reports.
A number of other brokerages have also recently weighed in
on JPM. Keefe, Bruyette & Woods cut JPMorgan Chase & Co. from an
“outperform” rating to a “market perform” rating and upped their price
objective for the stock from $125.00 to $130.00 in a research note on
Wednesday, November 18th. TheStreet upgraded shares of JPMorgan Chase & Co.
from a “c” rating to a “b-” rating in a report on Tuesday, August 4th. Deutsche
Bank Aktiengesellschaft upgraded shares of JPMorgan Chase & Co. from a
“hold” rating to a “buy” rating and boosted their price objective for the stock
from $105.00 to $115.00 in a research note on Thursday, September 3rd. Royal
Bank of Canada restated a “buy” rating and issued a $110.00 target price on
shares of JPMorgan Chase & Co. in a research note on Wednesday, October
14th. Finally, Independent Research raised JPMorgan Chase & Co. from a
“hold” rating to a “buy” rating and upped their price target for the stock from
$100.00 to $110.00 in a research report on Tuesday, September 29th. Two
investment analysts have rated the stock with a sell rating, seven have given a
hold rating and fifteen have issued a buy rating to the company. The company
currently has a consensus rating of “Buy” and an average target price of
$111.34. Read
more …
The Goldman Sachs Group (NYSE:GS) was downgraded by equities research analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating in a research note issued to investors on Monday, The Fly reports.
Other research analysts have also recently issued research
reports about the company. Citigroup boosted their price target on The Goldman
Sachs Group from $285.00 to $300.00 and gave the stock a "buy" rating
in a research note on Thursday, October 15th. Credit Suisse Group reiterated a
"buy" rating and issued a $262.00 price target (up previously from
$255.00) on shares of The Goldman Sachs Group in a research note on Monday,
October 19th. Barclays boosted their price target on The Goldman Sachs Group
from $253.00 to $270.00 and gave the stock an "equal weight" rating
in a research note on Thursday, October 15th. Bank of America boosted their
price target on The Goldman Sachs Group from $246.00 to $250.00 and gave the
stock a "buy" rating in a research note on Thursday, October 15th.
Finally, ValuEngine cut The Goldman Sachs Group from a "sell" rating
to a "strong sell" rating in a research note on Saturday, October
17th. Two analysts have rated the stock with a sell rating, five have assigned
a hold rating and fifteen have issued a buy rating to the company. The Goldman
Sachs Group currently has an average rating of "Buy" and an average
target price of $250.35. Read
more …
PPL (NYSE:PPL) was downgraded by research analysts at Bank of America from a “buy” rating to a “neutral” rating in a report released on Monday, The Fly reports.
PPL has been the subject of several other reports. Seaport
Global Securities raised shares of PPL from a “sell” rating to a “neutral”
rating in a report on Tuesday, August 11th. BMO Capital Markets decreased their
target price on shares of PPL from $37.00 to $36.00 and set an “outperform”
rating for the company in a research note on Friday, November 6th. Wells Fargo
& Company dropped their price target on PPL from $42.00 to $37.00 and set
an “overweight” rating on the stock in a research note on Monday, November
16th. Mizuho downgraded PPL from a “buy” rating to a “neutral” rating and
boosted their price target for the company from $28.50 to $29.50 in a research
note on Wednesday, August 19th. Finally, Morgan Stanley lifted their price
target on shares of PPL from $32.00 to $34.00 and gave the stock an “equal
weight” rating in a research note on Tuesday, November 17th. One equities
research analyst has rated the stock with a sell rating, eight have issued a
hold rating and nine have assigned a buy rating to the stock. The company
currently has an average rating of “Hold” and an average target price of
$36.23. Read
more …
Kinder Morgan (NYSE:KMI) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating in a report released on Monday, The Fly reports.
A number of other equities analysts have also issued reports
on KMI. Capital One Financial started coverage on Kinder Morgan in a report on
Wednesday, October 21st. They issued an "equal weight" rating for the
company. Credit Suisse Group decreased their price target on Kinder Morgan from
$20.00 to $16.00 and set an "outperform" rating for the company in a
research note on Tuesday, October 27th. Wolfe Research lowered Kinder Morgan
from a "peer perform" rating to an "underperform" rating
and increased their price target for the company from $13.00 to $14.00 in a
research note on Monday, November 23rd. ValuEngine lowered Kinder Morgan from a
"hold" rating to a "sell" rating in a research note on
Wednesday, September 16th. Finally, Stifel Nicolaus decreased their price
target on Kinder Morgan from $19.00 to $18.00 and set a "buy" rating
for the company in a research note on Monday, August 10th. Two analysts have
rated the stock with a sell rating, nine have given a hold rating and ten have given
a buy rating to the company's stock. Kinder Morgan has an average rating of
"Hold" and an average price target of $17.33. Read
more …
Sunoco (NYSE:SUN) was downgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “underweight” rating in a note issued to investors on Monday, The Fly reports.
SUN has been the subject of a number of other research
reports. Zacks Investment Research raised Sunoco from a “hold” rating to a
“strong-buy” rating and set a $28.00 price objective for the company in a
research note on Wednesday, October 21st. Credit Suisse Group increased their
price objective on Sunoco from $24.00 to $29.00 and gave the company a “neutral”
rating in a research note on Wednesday, August 12th. Royal Bank of Canada upped
their target price on Sunoco from $32.00 to $35.00 and gave the company an
“outperform” rating in a report on Thursday, November 12th. Finally, UBS Group
upped their target price on Sunoco from $31.00 to $32.00 and gave the company a
“buy” rating in a report on Thursday, November 5th. One analyst has rated the
stock with a sell rating, two have issued a hold rating, six have assigned a
buy rating and one has issued a strong buy rating to the company’s stock. The
company currently has a consensus rating of “Buy” and an average price target
of $28.88. Read more
…
Anheuser-Busch InBev SA/NV (NYSE:BUD) was downgraded by equities research analysts at Smith Barney Citigroup from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on Wednesday, The Fly reports.
Other analysts have also recently issued reports about the
company. Redburn Partners cut Anheuser-Busch InBev SA/NV from a “buy” rating to
a “neutral” rating in a report on Thursday, November 12th. Barclays reissued an
“equal weight” rating on shares of Anheuser-Busch InBev SA/NV in a report on
Friday, October 30th. Argus boosted their price objective on Anheuser-Busch
InBev SA/NV from $52.00 to $62.00 and gave the stock a “buy” rating in a report
on Tuesday, August 18th. Morgan Stanley reissued an “equal weight” rating on
shares of Anheuser-Busch InBev SA/NV in a report on Friday, October 9th.
Finally, Zacks Investment Research raised Anheuser-Busch InBev SA/NV from a
“strong sell” rating to a “hold” rating and set a $55.00 price objective for
the company in a report on Tuesday, November 3rd. Three research analysts have
rated the stock with a sell rating, sixteen have issued a hold rating and six
have issued a buy rating to the company. The company currently has an average
rating of “Hold” and a consensus target price of $56.20. Read
more …
Comments
Post a Comment